Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Kiniksa Pharmaceuticals Ltd
Interest Income Expense
Kiniksa Pharmaceuticals Ltd
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
|
Interest Income Expense
$9m
|
CAGR 3-Years
192%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
See Also
What is Kiniksa Pharmaceuticals Ltd's Interest Income Expense?
Interest Income Expense
9m
USD
Based on the financial report for Mar 31, 2024, Kiniksa Pharmaceuticals Ltd's Interest Income Expense amounts to 9m USD.
What is Kiniksa Pharmaceuticals Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
8%
Over the last year, the Interest Income Expense growth was 196%. The average annual Interest Income Expense growth rates for Kiniksa Pharmaceuticals Ltd have been 192% over the past three years , 8% over the past five years .